billS4106Event Monday, April 13, 2026Analyzed

A bill to amend title 10, United States Code, to improve access to certain medications under the TRICARE program, and for other purposes.

Bearish

Summary

S.4106 (Rx ACCESS Act) would change TRICARE pharmacy rules, allowing beneficiaries to get non-generic maintenance drugs at retail pharmacies and mandating cost-based PBM reimbursement. The bill is in early committee stage with bipartisan support. It would modestly benefit retail pharmacies like $WBA and pressure PBMs like $CI.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.S.4106 (Rx ACCESS Act) would change TRICARE pharmacy rules, benefiting retail pharmacies and pressuring PBMs.
  • 2.The bill is in committee with bipartisan support and a House companion, but early stage limits near-term impact.
  • 3.Market impact is moderate and concentrated in $WBA (bullish) and $CI (bearish).

Market Implications

The bill introduces regulatory changes to TRICARE's pharmacy benefit that directly affect two company types: retail pharmacies (Walgreens, ) and pharmacy benefit managers (Cigna, $CI). For , the mandated cost-plus reimbursement could improve margins on a small but recurring revenue stream. For $CI, the loss of spread revenue on TRICARE prescriptions could reduce segment profitability. However, given the small scale of TRICARE relative to these companies' total operations, the stock-level impact is likely muted unless the bill signals broader PBM reform. Investors should watch for movement out of committee and any amendments that expand the scope.

⚡ Government Convergence

VA / Government Health ITScore 77 · 3 channels · 162 events

Active government convergence in this signal’s sector right now.

Over the last 90 days, 162 separate government actions have converged on VA / Government Health IT. What that means: federal dollars are already moving — agencies are soliciting bids and awarding contracts, not just talking, and legislation and executive action are building the policy and funding tailwind behind it. When independent channels move together like this — 106 federal contracts, 30 bills and 26 procurement notices — it's the clearest early tell that Washington is committing to va / government health it, the kind of build-up that reshapes the sector well before it's obvious in the headlines.

Converging government actions

Full Analysis

S.4106, introduced in March 2026 by Sen. Cotton (R-AR) with five bipartisan cosponsors, is currently in the Senate Armed Services Committee. A companion bill (HR6400) exists in the House. The bill amends TRICARE pharmacy benefits to allow beneficiary choice of retail pharmacy for non-generic maintenance medications starting October 2026, and imposes reimbursement standards requiring the PBM contractor (Express Scripts, owned by Cigna) to pay retail pharmacies at least acquisition cost plus a dispensing fee. This is an authorization bill with no direct appropriations; it sets policy for the TRICARE program. The primary market impact is on pharmacy benefit managers (PBMs) and retail pharmacies. For PBMs like Cigna's Express Scripts, the mandated reimbursement formula reduces their ability to profit from the spread between what they pay pharmacies and what they charge the government. For retail pharmacies like Walgreens, the bill guarantees a minimum reimbursement, improving margins on TRICARE prescriptions. However, TRICARE covers only about 9.5 million beneficiaries, so the overall financial impact is small relative to these companies' total revenues. The legislative path is early but has bipartisan backing; passage is uncertain but possible within the 119th Congress. Structural winners are retail pharmacy chains; losers are PBMs with TRICARE contracts.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Unconfirmed

No confirming evidence found yet from contracts, insider trades, or congressional activity

$$CI▼ Bearish

What the bill does

Mandates cost-based reimbursement standards for TRICARE pharmacy benefit contracts, reducing PBM ability to capture spread between reimbursement and acquisition costs.

Who must act

Express Scripts (Cigna) as current TRICARE pharmacy contractor

What happens

Express Scripts faces reduced spread revenue on TRICARE prescriptions for non-generic maintenance drugs, lowering profit from the TRICARE contract.

Stock impact

Cigna's PBM segment (Express Scripts) derives a portion of revenue from TRICARE; reduced reimbursement flexibility may lower segment profit by an estimated amount, though TRICARE is a small part of overall PBM revenue.

Key Legislators

Sen. Cotton, Tom [R-AR]

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Exec OrderAug 6, 2026

Continuing to Protect the Meaning and Value of American Citizenship

This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.

Exec OrderAug 6, 2026

Ending Birth Tourism

This executive order directs the Secretaries of State and Homeland Security to prevent foreign nationals from entering the U.S. on nonimmigrant visas for the purpose of giving birth (birth tourism), including revoking visas, barring entry, and taking action against facilitators. It defines birth tourism as entry via nonimmigrant visa for childbirth and allows humanitarian or national interest exemptions.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →